Transmitted Drug Resistance Against Integrase Strand Transfer Inhibitors in Iranian HIV-Infected Naïve Patients
Open Access
- 18 June 2023
- journal article
- research article
- Published by Knowledge E DMCC in Avicenna Journal of Medical Biotechnology
- Vol. 15 (3) , 203-206
Abstract
Background: Human Immunodeficiency Virus (HIV) has claimed the lives of millions of people during the past decades. While several antiretroviral drugs like Integrase Strand Transfer Inhibitors (INSTIs) have been introduced to control HIV, Transmitted Drug Resistance (TDR) in HIV genome caused failure in treatment. This study aimed to investigate TDR and natural occurring mutations (NOPs) in HIV integrase gene in Iranian HIV patients. Methods: In this cross-sectional study, blood samples of 30 HIV-positive patients who had never taken integrase inhibitors were considered for CD4 T cell count, RT real-time PCR, and, Nested PCR. The sequencing results were analyzed by CLC sequence viewer software and Stanford University HIV Drug Resistance Database. Results: In all samples, nine NOPs with a high prevalence were found; however, we did not find any drug resistance mutations, except for a mutation in one sample, which showed a low resistance level. Subtype A1 was dominant in all samples. Conclusion: Based on the findings and compared to our previous study, all patients were sustainable to main integrase inhibitors, including bictegravir, raltegravir, bictegravir, elvitegravir and dolutegravir. It seems the resistant mutation pattern attributed to integrase inhibitors was not diffent among studied patients; hence, the prescription of such inhibitors helps physicians to control HIV infection in Iranian HIV-infected patients.Keywords
This publication has 11 references indexed in Scilit:
- First report on molecular docking analysis and drug resistance substitutions to approved HCV NS5A and NS5B inhibitors amongst Iranian patientsBMC Gastroenterology, 2021
- HIV drug resistance among naïve HIV-infected patients in IranJournal of Research in Medical Sciences, 2019
- Resistance to HIV Integrase Inhibitors: About R263K and E157Q MutationsViruses, 2018
- Bacterial etiology and antibiotic resistance pattern of septicemia in HIV and non-HIV patients admitted to tertiary care hospitals, Shiraz, South of IranCellular and Molecular Biology, 2017
- Subtype Classification of Iranian HIV-1 Sequences Registered in the HIV Databases, 2006-2013PLOS ONE, 2014
- Biochemical Analysis of the Role of G118R-Linked Dolutegravir Drug Resistance Substitutions in HIV-1 IntegraseAntimicrobial Agents and Chemotherapy, 2013
- Prevalence of Transmitted HIV Drug Resistance in Iran between 2010 and 2011PLOS ONE, 2013
- Broad Antiretroviral Activity and Resistance Profile of the Novel Human Immunodeficiency Virus Integrase Inhibitor Elvitegravir (JTK-303/GS-9137)Journal of Virology, 2008
- Molecular and phylogenetic analysis of HIV-1 variants circulating among injecting drug users in Mashhad-IranInfectious Agents and Cancer, 2006
- Molecular analysis and phylogenetic characterization of HIV in IranJournal of Medical Virology, 2006